secwatch / observer

8-K filed November 14, 2025, 6:59 PM ET ticker BNTC CIK 0001808898

earnings confidence high sentiment positive materiality 0.85

Benitec Q1 net loss $9.0M; BB-301 100% responder rate; FDA Fast Track; raised $100M

Benitec Biopharma Inc.

2026-Q1 EPS reported -$0.22 vs consensus -$0.28 ▲ beat (+21.2%)

Net loss of $9.0M ($0.22/sh) vs $5.1M ($0.18) YoY; total expenses $9.8M, up from $5.8M.
All 6 Cohort 1 patients in BB-301 Phase 1b/2a met formal response criteria (100% responder rate).
FDA granted Fast Track Designation for BB-301; first Cohort 2 patient dosed in Q4 2025.
Raised ~$100M in oversubscribed equity offering at $13.50/sh; cash $94.5M at Sep 30.
Appointed Sharon Mates (ex-CEO Intra-Cellular Therapies) to Board of Directors.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-283351
form_type: 8-K
ticker: BNTC
cik: 0001808898
company_name: Benitec Biopharma Inc.
filed_at: 2025-11-14T23:59:59+00:00
discovered_at: 2026-05-14T18:02:40.536850+00:00
generated_at: 2026-05-16T19:54:17.635363+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: positive
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-283351
json_url: https://secwatch.observer/filing/0001193125-25-283351.json
markdown_url: https://secwatch.observer/filing/0001193125-25-283351.md
text_url: https://secwatch.observer/filing/0001193125-25-283351.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312525283351/0001193125-25-283351-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1808898/000119312525283351/d811784d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

GMRS

GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B

GMR Solutions Inc. June 1, 2026, 4:45 PM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

HPE

HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework

Hewlett Packard Enterprise Co June 1, 2026, 4:09 PM ET earnings Items 1.01, 2.02, 5.02, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

CRDO

Credo Q4 revenue $437M (+157% YoY); guides Q1 $465-475M; CEO awarded 1.44M performance-based RSUs

Credo Technology Group Holding Ltd June 1, 2026, 4:08 PM ET earnings Items 2.02, 5.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

RMCF

Rocky Mountain Chocolate Factory Q4 revenue down 24% to $6.8M; net loss per share widens to $0.38

Rocky Mountain Chocolate Factory, Inc. June 1, 2026, 9:15 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

SAIC

SAIC Q1 adj EPS $3.23 beats $1.92; raises FY adj EBITDA and EPS guidance

Science Applications International Corp June 1, 2026, 6:55 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

FNGR

FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M

FingerMotion, Inc. May 29, 2026, 5:12 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

ELMT

Elmet Group Q1 revenue up 21% to $56M; adjusted EBITDA +106% to $9.2M; record backlog $113M

Elmet Group Co. May 29, 2026, 8:05 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

GCO

Genesco reports Q1 sales beat, raises FY2027 EPS outlook; launches $40-50M cost program

GENESCO INC May 29, 2026, 7:07 AM ET earnings Items 2.02, 9.01

same SEC item: 2.02, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001193125-25-283351

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.